Clinical Trials Directory

Trials / Completed

CompletedNCT05138510

Sexual Health in Breast Cancer Patients

Sexuality and Breast Cancer: Developing Appropriate Education for Women Going Through Treatment

Status
Completed
Phase
Study type
Observational
Enrollment
93 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

In the present study, we propose a mixed methods approach to characterize and address the sexual health needs among women with breast cancer at the time of diagnosis and throughout treatment.

Detailed description

In the present study, we propose a mixed methods approach to characterize and address the sexual health needs among women with breast cancer at the time of diagnosis and throughout treatment. The objectives are as follows: 1. To characterize the sexual well-being of women longitudinally throughout the continuum of care, from initial diagnosis into survivorship. We predict that treatment will adversely affect sexual well-being, and that patient factors, clinical factors, and treatment choices will influence changes in sexual well-being. 2. To identify gaps is sexual health education provided at the time of diagnosis or during treatment and to determine the appropriate timing of sexual health education delivery.

Conditions

Interventions

TypeNameDescription
BEHAVIORALFocus GroupProviders with extensive training and expertise in the subject will lead the virtual focus groups over Zoom using a semi-structured guide. Topics will focus on education received from the health care team, information received from outside sources, and patient recommendations on the type and timing of information preferred. We will create an analytic report based on the focus group findings, which will be used to inform the development of educational material. Sexual well-being is currently measured longitudinally on a 0-100 point scale as a component of a validated patient-reported outcome measures (PROM) survey (BREAST-Q) distributed to all breast cancer patients. These scores will be analyzed in patients with and without educational interventions for comparison.

Timeline

Start date
2020-12-01
Primary completion
2025-10-23
Completion
2025-10-23
First posted
2021-12-01
Last updated
2026-01-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05138510. Inclusion in this directory is not an endorsement.